Rezera(RZRA.US)递交IPO申请:口服NLRP3抑制剂管线推进,PAD三期试验计划2027年启动
Last Update:
23 10 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.